Global Blood Glucose Device Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Table of Contents1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Blood Glucose Device Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Blood Glucose Monitors
1.2.3 Glucose Monitoring Strips
1.2.4 Lancets
1.3 Market Segment by Application
1.3.1 Global Blood Glucose Device Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Hospitals
1.3.3 Diagnostics
1.3.4 Home Settings
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Blood Glucose Device Market Size (2017-2028)
2.1.1 Global Blood Glucose Device Revenue (2017-2028)
2.1.2 Global Blood Glucose Device Sales (2017-2028)
2.2 Global Blood Glucose Device Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Blood Glucose Device Sales by Regions (2017-2022)
2.2.2 Global Blood Glucose Device Revenue by Regions (2017-2022)
2.3 Global Blood Glucose Device Market Size Forecast by Region
2.3.1 Global Blood Glucose Device Sales Forecast by Region (2023-2028)
2.3.2 Global Blood Glucose Device Revenue Forecast by Region (2023-2028)
2.4 Global Top Blood Glucose Device Regions (Countries) Ranking by Market Size
2.5 Blood Glucose Device Market Dynamics
2.5.1 Blood Glucose Device Market Trends
2.5.2 Blood Glucose Device Market Drivers
2.5.3 Blood Glucose Device Market Challenges
2.5.4 Blood Glucose Device Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Blood Glucose Device Manufacturers by Sales (2017-2022)
3.1.1 Global Blood Glucose Device Sales by Manufacturers (2017-2022)
3.1.2 Global Blood Glucose Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Blood Glucose Device Sales in 2021
3.2 Global Top Manufacturers Blood Glucose Device by Revenue
3.2.1 Global Blood Glucose Device Revenue by Manufacturers (2017-2022)
3.2.2 Top Blood Glucose Device Manufacturers Covered: Ranking by Revenue
3.2.3 Global Blood Glucose Device Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Blood Glucose Device Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2021)
3.4 Global Blood Glucose Device Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Blood Glucose Device Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Blood Glucose Device Market
3.7 Key Manufacturers Blood Glucose Device Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Blood Glucose Device Market Size by Type
4.1 Global Blood Glucose Device Historic Market Review by Type (2017-2022)
4.1.1 Global Blood Glucose Device Sales Market Share by Type (2017-2022)
4.1.2 Global Blood Glucose Device Revenue Market Share by Type (2017-2022)
4.1.3 Blood Glucose Device Price by Type (2017-2022)
4.2 Global Blood Glucose Device Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Blood Glucose Device Sales Forecast by Type (2023-2028)
4.2.2 Global Blood Glucose Device Revenue Forecast by Type (2023-2028)
4.2.3 Blood Glucose Device Price Forecast by Type (2023-2028)
5 Global Blood Glucose Device Market Size by Application
5.1 Global Blood Glucose Device Historic Market Review by Application (2017-2022)
5.1.1 Global Blood Glucose Device Sales Market Share by Application (2017-2022)
5.1.2 Global Blood Glucose Device Revenue Market Share by Application (2017-2022)
5.1.3 Blood Glucose Device Price by Application (2017-2022)
5.2 Global Blood Glucose Device Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Blood Glucose Device Sales Forecast by Application (2023-2028)
5.2.2 Global Blood Glucose Device Revenue Forecast by Application (2023-2028)
5.2.3 Blood Glucose Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Blood Glucose Device Sales Breakdown by Company
6.1.1 North America Blood Glucose Device Sales by Company (2017-2022)
6.1.2 North America Blood Glucose Device Revenue by Company (2017-2022)
6.2 North America Blood Glucose Device Market Size by Type
6.2.1 North America Blood Glucose Device Sales by Type (2017-2028)
6.2.2 North America Blood Glucose Device Revenue by Type (2017-2028)
6.3 North America Blood Glucose Device Market Size by Application
6.3.1 North America Blood Glucose Device Sales by Application (2017-2028)
6.3.2 North America Blood Glucose Device Revenue by Application (2017-2028)
6.4 North America Blood Glucose Device Market Size by Country
6.4.1 North America Blood Glucose Device Sales by Country (2017-2028)
6.4.2 North America Blood Glucose Device Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Blood Glucose Device Sales Breakdown by Company
7.1.1 Europe Blood Glucose Device Sales by Company (2017-2022)
7.1.2 Europe Blood Glucose Device Revenue by Company (2017-2022)
7.2 Europe Blood Glucose Device Market Size by Type
7.2.1 Europe Blood Glucose Device Sales by Type (2017-2028)
7.2.2 Europe Blood Glucose Device Revenue by Type (2017-2028)
7.3 Europe Blood Glucose Device Market Size by Application
7.3.1 Europe Blood Glucose Device Sales by Application (2017-2028)
7.3.2 Europe Blood Glucose Device Revenue by Application (2017-2028)
7.4 Europe Blood Glucose Device Market Size by Country
7.4.1 Europe Blood Glucose Device Sales by Country (2017-2028)
7.4.2 Europe Blood Glucose Device Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Blood Glucose Device Sales Breakdown by Company
8.1.1 Asia Pacific Blood Glucose Device Sales by Company (2017-2022)
8.1.2 Asia Pacific Blood Glucose Device Revenue by Company (2017-2022)
8.2 Asia Pacific Blood Glucose Device Market Size by Type
8.2.1 Asia Pacific Blood Glucose Device Sales by Type (2017-2028)
8.2.2 Asia Pacific Blood Glucose Device Revenue by Type (2017-2028)
8.3 Asia Pacific Blood Glucose Device Market Size by Application
8.3.1 Asia Pacific Blood Glucose Device Sales by Application (2017-2028)
8.3.2 Asia Pacific Blood Glucose Device Revenue by Application (2017-2028)
8.4 Asia Pacific Blood Glucose Device Market Size by Region
8.4.1 Asia Pacific Blood Glucose Device Sales by Region
8.4.2 Asia Pacific Blood Glucose Device Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Blood Glucose Device Sales Breakdown by Company
9.1.1 Latin America Blood Glucose Device Sales by Company (2017-2022)
9.1.2 Latin America Blood Glucose Device Revenue by Company (2017-2022)
9.2 Latin America Blood Glucose Device Market Size by Type
9.2.1 Latin America Blood Glucose Device Sales by Type (2017-2028)
9.2.2 Latin America Blood Glucose Device Revenue by Type (2017-2028)
9.3 Latin America Blood Glucose Device Market Size by Application
9.3.1 Latin America Blood Glucose Device Sales by Application (2017-2028)
9.3.2 Latin America Blood Glucose Device Revenue by Application (2017-2028)
9.4 Latin America Blood Glucose Device Market Size by Country
9.4.1 Latin America Blood Glucose Device Sales by Country (2017-2028)
9.4.2 Latin America Blood Glucose Device Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Blood Glucose Device Sales Breakdown by Company
10.1.1 Middle East and Africa Blood Glucose Device Sales by Company (2017-2022)
10.1.2 Middle East and Africa Blood Glucose Device Revenue by Company (2017-2022)
10.2 Middle East and Africa Blood Glucose Device Market Size by Type
10.2.1 Middle East and Africa Blood Glucose Device Sales by Type (2017-2028)
10.2.2 Middle East and Africa Blood Glucose Device Revenue by Type (2017-2028)
10.3 Middle East and Africa Blood Glucose Device Market Size by Application
10.3.1 Middle East and Africa Blood Glucose Device Sales by Application (2017-2028)
10.3.2 Middle East and Africa Blood Glucose Device Revenue by Application (2017-2028)
10.4 Middle East and Africa Blood Glucose Device Market Size by Country
10.4.1 Middle East and Africa Blood Glucose Device Sales by Country (2017-2028)
10.4.2 Middle East and Africa Blood Glucose Device Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Abbott Laboratories (U.S.)
11.1.1 Abbott Laboratories (U.S.) Corporation Information
11.1.2 Abbott Laboratories (U.S.) Overview
11.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories (U.S.) Blood Glucose Device Products and Services
11.1.5 Abbott Laboratories (U.S.) Blood Glucose Device SWOT Analysis
11.1.6 Abbott Laboratories (U.S.) Recent Developments
11.2 ARKRAY (Japan)
11.2.1 ARKRAY (Japan) Corporation Information
11.2.2 ARKRAY (Japan) Overview
11.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 ARKRAY (Japan) Blood Glucose Device Products and Services
11.2.5 ARKRAY (Japan) Blood Glucose Device SWOT Analysis
11.2.6 ARKRAY (Japan) Recent Developments
11.3 Dexcom (U.S.)
11.3.1 Dexcom (U.S.) Corporation Information
11.3.2 Dexcom (U.S.) Overview
11.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Dexcom (U.S.) Blood Glucose Device Products and Services
11.3.5 Dexcom (U.S.) Blood Glucose Device SWOT Analysis
11.3.6 Dexcom (U.S.) Recent Developments
11.4 F.Hoffmann-La Roche Ltd (Switzerland)
11.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Overview
11.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Products and Services
11.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device SWOT Analysis
11.4.6 F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
11.5 Johnson & Johnson (U.S.)
11.5.1 Johnson & Johnson (U.S.) Corporation Information
11.5.2 Johnson & Johnson (U.S.) Overview
11.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson (U.S.) Blood Glucose Device Products and Services
11.5.5 Johnson & Johnson (U.S.) Blood Glucose Device SWOT Analysis
11.5.6 Johnson & Johnson (U.S.) Recent Developments
11.6 Medtronic (U.S.)
11.6.1 Medtronic (U.S.) Corporation Information
11.6.2 Medtronic (U.S.) Overview
11.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Medtronic (U.S.) Blood Glucose Device Products and Services
11.6.5 Medtronic (U.S.) Blood Glucose Device SWOT Analysis
11.6.6 Medtronic (U.S.) Recent Developments
11.7 Nipro Diagnostics (U.S.)
11.7.1 Nipro Diagnostics (U.S.) Corporation Information
11.7.2 Nipro Diagnostics (U.S.) Overview
11.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Nipro Diagnostics (U.S.) Blood Glucose Device Products and Services
11.7.5 Nipro Diagnostics (U.S.) Blood Glucose Device SWOT Analysis
11.7.6 Nipro Diagnostics (U.S.) Recent Developments
11.8 Terumo Medical Corporation (U.S.)
11.8.1 Terumo Medical Corporation (U.S.) Corporation Information
11.8.2 Terumo Medical Corporation (U.S.) Overview
11.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Terumo Medical Corporation (U.S.) Blood Glucose Device Products and Services
11.8.5 Terumo Medical Corporation (U.S.) Blood Glucose Device SWOT Analysis
11.8.6 Terumo Medical Corporation (U.S.) Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Blood Glucose Device Value Chain Analysis
12.2 Blood Glucose Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blood Glucose Device Production Mode & Process
12.4 Blood Glucose Device Sales and Marketing
12.4.1 Blood Glucose Device Sales Channels
12.4.2 Blood Glucose Device Distributors
12.5 Blood Glucose Device Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of TablesTable 1. Global Blood Glucose Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Blood Glucose Monitors
Table 3. Major Manufacturers of Glucose Monitoring Strips
Table 4. Major Manufacturers of Lancets
Table 5. Global Blood Glucose Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Blood Glucose Device Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 8. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Table 9. Global Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Blood Glucose Device Revenue Market Share by Region (2017-2022)
Table 11. Global Blood Glucose Device Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Blood Glucose Device Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Blood Glucose Device Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Blood Glucose Device Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Blood Glucose Device Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Blood Glucose Device Market Trends
Table 17. Blood Glucose Device Market Drivers
Table 18. Blood Glucose Device Market Challenges
Table 19. Blood Glucose Device Market Restraints
Table 20. Global Blood Glucose Device Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Blood Glucose Device Sales Share by Manufacturers (2017-2022)
Table 22. Global Blood Glucose Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Blood Glucose Device Manufacturers by Revenue (US$ Million) in 2021
Table 24. Blood Glucose Device Revenue Share by Manufacturers (2017-2022)
Table 25. Global Blood Glucose Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2021)
Table 27. Key Manufacturers Blood Glucose Device Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 28. Key Manufacturers Blood Glucose Device Plants/Factories Distribution
Table 29. Key Manufacturers Blood Glucose Device Area Served
Table 30. Date of Key Manufacturers Enter into Blood Glucose Device Market
Table 31. Key Manufacturers Blood Glucose Device Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Blood Glucose Device Sales (K Units) by Type (2017-2022)
Table 34. Global Blood Glucose Device Sales Share by Type (2017-2022)
Table 35. Global Blood Glucose Device Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Blood Glucose Device Price (K Units) by Type (2017-2022)
Table 37. Global Blood Glucose Device Sales (K Units) by Type (2023-2028)
Table 38. Global Blood Glucose Device Sales Share by Type (2023-2028)
Table 39. Global Blood Glucose Device Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Blood Glucose Device Revenue Share by Type (2023-2028)
Table 41. Global Blood Glucose Device Price (K Units) by Type (2023-2028)
Table 42. Global Blood Glucose Device Sales (K Units) by Application (2017-2022)
Table 43. Global Blood Glucose Device Sales Share by Application (2017-2022)
Table 44. Global Blood Glucose Device Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Blood Glucose Device Price (K Units) by Application (2017-2022)
Table 46. Global Blood Glucose Device Sales (K Units) by Application (2023-2028)
Table 47. Global Blood Glucose Device Sales Share by Application (2023-2028)
Table 48. Global Blood Glucose Device Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Blood Glucose Device Revenue Share by Application (2023-2028)
Table 50. Global Blood Glucose Device Price (K Units) by Application (2023-2028)
Table 51. North America Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 52. North America Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 53. North America Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 55. North America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 56. North America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 57. North America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 60. North America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 61. North America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 64. North America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 65. North America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 68. Europe Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 69. Europe Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 71. Europe Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 72. Europe Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 73. Europe Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 76. Europe Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 77. Europe Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 80. Europe Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 81. Europe Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Blood Glucose Device Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Blood Glucose Device Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 101. Latin America Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 103. Latin America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Blood Glucose Device Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Blood Glucose Device Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Blood Glucose Device Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Blood Glucose Device Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 131. Abbott Laboratories (U.S.) Corporation Information
Table 132. Abbott Laboratories (U.S.) Description and Overview
Table 133. Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 134. Abbott Laboratories (U.S.) Blood Glucose Device Product and Services
Table 135. Abbott Laboratories (U.S.) Blood Glucose Device SWOT Analysis
Table 136. Abbott Laboratories (U.S.) Recent Developments
Table 137. ARKRAY (Japan) Corporation Information
Table 138. ARKRAY (Japan) Description and Overview
Table 139. ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 140. ARKRAY (Japan) Blood Glucose Device Product and Services
Table 141. ARKRAY (Japan) Blood Glucose Device SWOT Analysis
Table 142. ARKRAY (Japan) Recent Developments
Table 143. Dexcom (U.S.) Corporation Information
Table 144. Dexcom (U.S.) Description and Overview
Table 145. Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 146. Dexcom (U.S.) Blood Glucose Device Product and Services
Table 147. Dexcom (U.S.) Blood Glucose Device SWOT Analysis
Table 148. Dexcom (U.S.) Recent Developments
Table 149. F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 150. F.Hoffmann-La Roche Ltd (Switzerland) Description and Overview
Table 151. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 152. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product and Services
Table 153. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device SWOT Analysis
Table 154. F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
Table 155. Johnson & Johnson (U.S.) Corporation Information
Table 156. Johnson & Johnson (U.S.) Description and Overview
Table 157. Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 158. Johnson & Johnson (U.S.) Blood Glucose Device Product and Services
Table 159. Johnson & Johnson (U.S.) Blood Glucose Device SWOT Analysis
Table 160. Johnson & Johnson (U.S.) Recent Developments
Table 161. Medtronic (U.S.) Corporation Information
Table 162. Medtronic (U.S.) Description and Overview
Table 163. Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 164. Medtronic (U.S.) Blood Glucose Device Product and Services
Table 165. Medtronic (U.S.) Blood Glucose Device SWOT Analysis
Table 166. Medtronic (U.S.) Recent Developments
Table 167. Nipro Diagnostics (U.S.) Corporation Information
Table 168. Nipro Diagnostics (U.S.) Description and Overview
Table 169. Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 170. Nipro Diagnostics (U.S.) Blood Glucose Device Product and Services
Table 171. Nipro Diagnostics (U.S.) Blood Glucose Device SWOT Analysis
Table 172. Nipro Diagnostics (U.S.) Recent Developments
Table 173. Terumo Medical Corporation (U.S.) Corporation Information
Table 174. Terumo Medical Corporation (U.S.) Description and Overview
Table 175. Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 176. Terumo Medical Corporation (U.S.) Blood Glucose Device Product and Services
Table 177. Terumo Medical Corporation (U.S.) Blood Glucose Device SWOT Analysis
Table 178. Terumo Medical Corporation (U.S.) Recent Developments
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Blood Glucose Device Distributors List
Table 182. Blood Glucose Device Customers List
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
List of FiguresFigure 1. Blood Glucose Device Product Picture
Figure 2. Global Blood Glucose Device Sales Market Share by Type in 2021 & 2028
Figure 3. Blood Glucose Monitors Product Picture
Figure 4. Glucose Monitoring Strips Product Picture
Figure 5. Lancets Product Picture
Figure 6. Global Blood Glucose Device Sales Market Share by Application in 2021 & 2028
Figure 7. Hospitals Use Case
Figure 8. Diagnostics Use Case
Figure 9. Home Settings Use Case
Figure 10. Others Use Case
Figure 11. Blood Glucose Device Report Years Considered
Figure 12. Global Blood Glucose Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Blood Glucose Device Market Size 2017-2028 (US$ Million)
Figure 14. Global Blood Glucose Device Sales (2017-2022) & (K Units)
Figure 15. Global Blood Glucose Device Market Size Market Share by Region: 2021 VS 2028
Figure 16. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Figure 17. Global Blood Glucose Device Sales Market Share by Region in 2021
Figure 18. Global Blood Glucose Device Revenue Market Share by Region in 2017 VS 2021
Figure 19. Global Blood Glucose Device Sales Share by Manufacturers in 2021
Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Blood Glucose Device Sales in 2021
Figure 21. Blood Glucose Device Revenue Share by Manufacturers in 2021
Figure 22. Blood Glucose Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 23. Global Blood Glucose Device Revenue Share by Type (2017-2022)
Figure 24. Global Blood Glucose Device Revenue Growth Rate by Type in 2017 & 2021
Figure 25. Global Blood Glucose Device Revenue Share by Application (2017-2022)
Figure 26. Global Blood Glucose Device Revenue Growth Rate by Application in 2017 & 2021
Figure 27. North America Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 28. North America Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 29. North America Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure